Michael S. Rooney
Molecular Biology · 2015–2020
A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 76 citations into it
- Immunology — 63 citations into it; #1,639 of 2,160 by trust here, #456 by citations
- Artificial Intelligence — 7 citations into it
Whom Michael S. Rooney trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Ben Langmead
- Robert Schreiber
- Padmanee Sharma
- Lloyd J. Old
- Steven L. Salzberg
- N. Restifo
- Franck Pagès
- D. Barbie
Who trusts Michael S. Rooney overall
Papers from Michael S. Rooney's perspective
Ordered by how strongly the researchers Michael S. Rooney trusts endorse each paper. Same corpus, a different order for every researcher.
- An immune-active tumor microenvironment favors clinical response to ipilimumab (Cancer Immunology and Immunotherapy)
- Novel cancer immunotherapy agents with survival benefit: recent successes and next steps (Nature Reviews. Cancer)
- Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
- Neoantigens in cancer immunotherapy (Science)
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma (Nature Medicine)
- Gapped sequence alignment using artificial neural networks: application to the MHC class I system
- Effector memory T cells, early metastasis, and survival in colorectal cancer. (New England Journal of Medicine)
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (Nature)
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (Nature Medicine)
- NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 (Nucleic Acids Res.)
Their papers
- Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction (2017) — 600 citations
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. (2020) — 621 citations
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation (2017) — 857 citations
- Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes (2015) — 596 citations
- Molecular and genetic properties of tumors associated with local immune cytolytic activity (2015) — 3,255 citations